CRESUD S.A.-SPONS ADR (CRESY)

US2264061068 - ADR

8.3395  +0.19 (+2.33%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CRESY. CRESY was compared to 93 industry peers in the Food Products industry. While CRESY has a great profitability rating, there are quite some concerns on its financial health. CRESY is quite expensive at the moment. It does show a decent growth rate.



7

1. Profitability

1.1 Basic Checks

In multiple years CRESY reported negative net income over the last 5 years.
CRESY had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

CRESY has a Return On Assets (3.38%) which is in line with its industry peers.
CRESY's Return On Equity of 19.17% is amongst the best of the industry. CRESY outperforms 89.13% of its industry peers.
CRESY has a Return On Invested Capital (3.01%) which is in line with its industry peers.
CRESY had an Average Return On Invested Capital over the past 3 years of 1.24%. This is significantly below the industry average of 7.70%.
The 3 year average ROIC (1.24%) for CRESY is below the current ROIC(3.01%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.38%
ROE 19.17%
ROIC 3.01%
ROA(3y)0.99%
ROA(5y)-0.33%
ROE(3y)-6.05%
ROE(5y)-31.99%
ROIC(3y)1.24%
ROIC(5y)1.35%

1.3 Margins

Looking at the Profit Margin, with a value of 23.04%, CRESY belongs to the top of the industry, outperforming 96.74% of the companies in the same industry.
In the last couple of years the Profit Margin of CRESY has grown nicely.
The Operating Margin of CRESY (21.02%) is better than 98.91% of its industry peers.
In the last couple of years the Operating Margin of CRESY has grown nicely.
With an excellent Gross Margin value of 42.52%, CRESY belongs to the best of the industry, outperforming 94.57% of the companies in the same industry.
CRESY's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 21.02%
PM (TTM) 23.04%
GM 42.52%
OM growth 3Y-15.85%
OM growth 5Y6.83%
PM growth 3Y23.52%
PM growth 5Y27.63%
GM growth 3Y3.55%
GM growth 5Y2.3%

2

2. Health

2.1 Basic Checks

CRESY has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CRESY has been increased compared to 5 years ago.
Compared to 1 year ago, CRESY has an improved debt to assets ratio.

2.2 Solvency

The Debt to FCF ratio of CRESY is 17.56, which is on the high side as it means it would take CRESY, 17.56 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 17.56, CRESY is in line with its industry, outperforming 51.09% of the companies in the same industry.
CRESY has a Debt/Equity ratio of 1.14. This is a high value indicating a heavy dependency on external financing.
CRESY's Debt to Equity ratio of 1.14 is on the low side compared to the rest of the industry. CRESY is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 17.56
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.18 indicates that CRESY should not have too much problems paying its short term obligations.
The Current ratio of CRESY (1.18) is worse than 64.13% of its industry peers.
A Quick Ratio of 0.89 indicates that CRESY may have some problems paying its short term obligations.
CRESY has a Quick ratio (0.89) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.89

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 336.84% over the past year.
CRESY shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 41.82% yearly.
CRESY shows a strong growth in Revenue. In the last year, the Revenue has grown by 224.92%.
CRESY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.34% yearly.
EPS 1Y (TTM)336.84%
EPS 3Y50.43%
EPS 5Y41.82%
EPS Q2Q%-353.9%
Revenue 1Y (TTM)224.92%
Revenue growth 3Y32.29%
Revenue growth 5Y15.34%
Sales Q2Q%531.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The decent profitability rating of CRESY may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CRESY!.
Industry RankSector Rank
Dividend Yield N/A

CRESUD S.A.-SPONS ADR

NASDAQ:CRESY (6/12/2024, 9:39:09 AM)

8.3395

+0.19 (+2.33%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap492.27M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.38%
ROE 19.17%
ROCE
ROIC
ROICexc
ROICexgc
OM 21.02%
PM (TTM) 23.04%
GM 42.52%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.18
Quick Ratio 0.89
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)336.84%
EPS 3Y50.43%
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)224.92%
Revenue growth 3Y32.29%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y